SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-001800
Filing Date
2024-01-25
Accepted
2024-01-25 16:10:16
Documents
1
Period of Report
2024-01-23

Document Format Files

Seq Description Document Type Size
1 form4-01252024_040111.html 4  
1 form4-01252024_040111.xml 4 3751
  Complete submission text file 0001415889-24-001800.txt   5413
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RETROPHIN, INC. 3721 VALLEY CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
ROTE WILLIAM E. (Reporting) CIK: 0001698262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 24562240